Investments in the digital health sector dropped from $15.3 billion to $10.7 billion in 2023, leading to a need for reshaping digital therapeutics for better clinical effectiveness. Dr. Guido Giunti, a digital therapeutics researcher, discussed patient involvement in developing these tools, emphasizing the importance of inclusivity. He highlighted the impact of participatory design and the challenges of targeting specific populations. Giunti stressed the need for developers to understand their target audience and path to reimbursement while adapting to the ever-changing digital landscape. He emphasized the importance of creating a variety of solutions tailored to different patient needs rather than relying on a single “cure-all app.”
Source link
Q&A: Creating digital therapeutics for patient impact and profitability
